Literature DB >> 179126

Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy.

K Liewendahl, H Majuri.   

Abstract

Clinical laboratory tests for assessment of thyroid function were performed in 31 patients receiving long-term diphenylhydantoin (DPH) therapy. Reduced serum total thyroxine and free thyroxine index were found. The decrease in serum total triiodothyronine and free triiodothyronine index was smaller but statistically significant. DPH had no significant effect on the serum thyrotropin (TSH) concentration and maximal TSH response to TSH-releasing hormone. The absence of reciprocal changes in TSH and serum thyroxine might be due to the near-normal triiodothyronine concentration. Such an explanation would also conform with previous findings that the pituitary contains specific receptors for triiodothyronine but not thyroxine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 179126

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

Review 1.  Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction.

Authors:  M Strolin Benedetti; R Whomsley; E Baltes; F Tonner
Journal:  Eur J Clin Pharmacol       Date:  2005-11-24       Impact factor: 2.953

2.  Anticonvulsants and thyroid function.

Authors:  P P Yeo; D Bates; J G Howe; W A Ratcliffe; C W Schardt; A Heath; D C Evered
Journal:  Br Med J       Date:  1978-06-17

3.  A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.

Authors:  E E Ohnhaus; H Studer
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic.

Authors:  A A Connacher; D Q Borsey; M C Browning; D L Davidson; R T Jung
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.